Articles published by Ligand Pharmaceuticals Incorporated
![](https://mms.businesswire.com/media/20240820748761/en/1990362/5/New_Ligand_Logo.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240806965162/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240723930890/en/1990362/5/New_Ligand_Logo.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240706652097/en/1990362/5/New_Ligand_Logo.jpg)
Ligand to Acquire APEIRON Biologics AG for $100 Million
July 08, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240627518993/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240618130919/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240523216667/en/1990362/5/New_Ligand_Logo.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240507633610/en/2123419/5/logo.jpg)
![](https://mms.businesswire.com/media/20240507973195/en/2122485/5/Ligand_full_color_logo_FINAL.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240423025889/en/2106309/5/logo.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240408525422/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240403857451/en/2087841/22/Scott_Plesha_CEO_Pelthos_Therapeutics.jpg)
![](https://mms.businesswire.com/media/20240305561022/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
March 05, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240304017350/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240227868201/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240222424618/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240215878741/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
February 16, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240213620099/en/1990362/5/New_Ligand_Logo.jpg)
Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
February 13, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240201924216/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2024
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20240105377376/en/1990356/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20231212987229/en/1967452/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20231206842106/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20231108320171/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Third Quarter 2023 Financial Results
November 08, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20231101846503/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
November 01, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20231025648141/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand To Report Third Quarter 2023 Financial Results On November 8
October 25, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230927379411/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Acquires Assets of Novan, Inc. for $12.2 Million
September 27, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230926107866/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Appoints Martine Zimmermann to its Board of Directors
September 26, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230922394712/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230921058683/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230918188983/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio
September 18, 2023
Via Business Wire
Tickers
LGND
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.